Sarissa Capital seeks to replace Ariad CEO - CNBC

Feb 12 (Reuters) - Activist hedge fund Sarissa Capital is looking to replace Ariad Pharmaceuticals Inc's chief executive and could mount a proxy fight in the next few weeks, CNBC reported, citing a source. http://cnb.cx/1DmFQnW

from Reuters: Company News http://ift.tt/1J5rCwH

via IFTTT